Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

FFA and FAPD might be related or stages of the same disease.

Fisetin, found in fruits and vegetables, may help treat various health conditions like inflammation, diabetes, heart issues, cancer, and hair loss.

Finasteride blocks progesterone's effect on absence seizures in rats.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Tofacitinib may help regrow hair in alopecia areata patients.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Fucoidan may help regrow hair and reduce inflammation in hair loss.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Fzd2 is important for skin and hair development through various signaling ways.

Ferulic acid can reduce seizures and depression-like behaviors in catamenial epilepsy by balancing hormones and brain enzyme activity.

Neurosteroid withdrawal increases seizure frequency in a rat model of catamenial epilepsy.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.